Interestingly, the results of six large-scale clinical studies have reported a remarkably consistent 14–34% reduction in the incidence of diabetes in hypertensive patients treated with ACE inhibitors for 3–6 years [145]. The gene discussed is ACE; the disease is diabetes mellitus.